TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

MLTX DEADLINE: ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
MLTX DEADLINE: ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

Rosen Law Firm is pursuing a securities class action against MoonLake Immunotherapeutics, alleging false and misleading statements about their Nanobody technology's clinical benefits and efficacy during the period of March 10, 2024 to September 29, 2025.

Insights
NVDA   positive

Strategic partner with ASML, leading AI semiconductor chip manufacturer with high market demand


MLTX   negative

The lawsuit alleges the company made false statements about its Nanobody technology's clinical advantages, suggesting potential misrepresentation of scientific claims and potential investor harm